SERETIDE 100/50 bd (Twice Daily) Versus FLIXOTIDE 100 bd As Initial Maintenance Therapy In Moderate Asthma In Adults
Status:
Completed
Trial end date:
2007-12-01
Target enrollment:
Participant gender:
Summary
This study will compare during 12 weeks, two treatment strategies for Initial Maintenance
Therapy : fluticasone propionate alone or the salmeterol/fluticasone propionate combination
in adults with moderate persistent asthma
Phase:
Phase 4
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Fluticasone Fluticasone Propionate, Salmeterol Xinafoate Drug Combination Salmeterol Xinafoate Xhance